Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease.

Pulmonary and Critical Care Associates of Baltimore (PCCAB)

Status

Completed

Conditions

Asthma

Copd

Treatments

Device: Respimetrix

Study type

Interventional

Funder types

Other

Identifiers

NCT05495256

Respimetrix 2

Details and patient eligibility

About

To Determine whether use of the Respimetrix flow test device a) can determine "good" versus "poor" inhaler techniques, and b) the effects of the inhaler training on technique.

Full description

Good metered dose inhaler (MDI) technique is described as sitting or standing upright with the head slightly tilted back, exhaling fully, and then inhaling slowly and deeply as you activate the MDI. Common mistakes include: not exhaling fully; not inhaling deeply enough; inhaling too quickly, and not activating the MDI at the proper time.

This study will use the Respimetrix device with placebo to assess a patient's inhaler technique, provide training to patients who demonstrate poor inhaler technique, and remotely track a subject's breathing ability over time.

Enrollment

74 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients 18 years of age or older
Current diagnosis of asthma or Chronic obstructive pulmonary disease (COPD) patients
Patients must be willing and able to provide informed consent to participate in the the study.
Patients must be able to use a metered dose inhaler

Exclusion criteria

Contraindication to inhaler use
Tracheostomy
Incapacitating disability that interferes with the use of the inhaler or execution of the protocol
Unable to understand informed consent (e.g. non-English speakers)